Ann: Half Year Accounts, page-158

For me, the half yearly showed that the Hemp business alone isn't scalable in Australia to profitability, and their biggest issue may be that overseas companies are so far ahead of them in terms of reliable supply, product range, cost optimisation etc that expansion outside Australia is not a viable option either. As I said, Hemp products are widely varied here in Canada (for that matter 'weed' products are too, but doubt Australia is heading for recreational legalisation anytime soon lol).

I haven't read enough into Biohealth, but someone in this thread mentioned that the founder of Biohealth stated they have not built their facility yet? Is that true?

I know Medcan was meant to have a huge facility upgrade under the purchase agreement, but the new one says Medcan will be doing this as an activity for CGB, which I am not sure if that's started yet?

This half yearly had lots of nice pictures upfront, and not much progress in the back. If I were an investor, that would worry me as it's similar to the pattern these guys had with bauxite years ago. They were in an industry they didn't understand, and making promises they couldn't keep up with. You can go back to 2013/2014 and read my comments on the bauxite stuff they tried, it was pretty appalling. I had hoped they'd turned over a new leaf with this stuff, but the same directors concerns me. Hope they have some great advisers (which you mentioned they may have)